Thyroid Carcinoma
📧 Sign up to get email alerts when something new happens for Thyroid Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Study of IK-595 in RAS- or RAF-altered Advanced Tumors [Phase 1]
Phase 1 study of IK-595 in Ras- or Raf-altered advanced tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating dabrafenib with or without trametinib in advanced differentiated thyroid carcinoma, including follicular, papillary…
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System [Phase 2]
Phase 2 trial evaluating whether artificial tears influence radioiodine levels in the nasolacrimal duct system in thyroid carcinoma patients…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults [Phase 4]
Phase 4 clinical trial update assessing optimal dosing of oral anticancer drugs in older adults, with multiple cancer indications listed.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma [Phase 2]
Phase 2 study of sulfatinib for advanced medullary thyroid carcinoma and iodine-refractory differentiated thyroid carcinoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma [Phase 2]
Phase II clinical trial evaluating the optimal administration scheme of pazopanib in thyroid carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer [Phase 2]
Phase 2 trial of cabozantinib-s-malate in patients with refractory thyroid cancer has been completed, with results posted in 2018. The study…
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery [Phase 2]
This Phase 2 trial evaluated Sunitinib malate in iodine-refractory thyroid cancers, including differentiated and medullary subtypes. Results…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study Into the Effect of Seprafilm in Open Total Thyroidectomy [NA]
A terminated clinical trial evaluated Seprafilm as an adhesion barrier during open total thyroidectomy for thyroid carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Trial of LBH589 in Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial update for LBH589 (panobinostat) in metastatic thyroid carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function
A completed trial investigates reimplanting parathyroid tissue into forearm subcutaneous tissue during thyroidectomy to prevent hypoparathyr…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies [Phase 1]
Phase 1 study of cabozantinib (XL184) in adults with advanced malignancies, including lymphoma and thyroid carcinoma, has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-27Clinical Trial Update: Lipid Metabolic Status in Thyroid Carcinoma
This clinical trial (NCT01487057) on lipid metabolic status in thyroid carcinoma has completed. It includes aspects related to dyslipidemias…
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Lacrimal Drainage System Obstruction Associated to Radioactive Iodine Therapy for Thyroid Carcinoma [NA]
This clinical trial update notes lacrimal drainage obstruction associated with radioactive iodine therapy for thyroid carcinoma, with the tr…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain [Phase 3]
Phase 3 trial evaluating fibrin sealant to reduce post-thyroidectomy drain; results posted in 2011.